Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-14

Clinical Trial Update: Use of Selincro and Impact on Usual Practice

View source ↗

Summary

This clinical trial update discusses the use of Selincro (nalmefene) for alcohol dependence and its impact on usual clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selincro (nalmefene hydrochloride dihydrate)

Snippet

Sponsor: University of Bordeaux | Conditions: Alcohol Dependence | Status: COMPLETED